We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Biogen and Bio-Thera Solutions Partner Over Actemra Biosimilar
Biogen and Bio-Thera Solutions Partner Over Actemra Biosimilar
Biogen and Chinese drugmaker Bio-Thera Solutions have teamed to develop a biosimilar of Roche’s Actemra (tocilizumab), BAT1806, currently being evaluated in phase 3 trials for moderate-to-severe rheumatoid arthritis.